Bionano Genomics Inc (NASDAQ:BNGO) price on Wednesday, December 04, rose 0.80% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.24.
A look at the stock’s price movement, the close in the last trading session was $0.24, moving within a range at $0.2307 and $0.2489. The beta value (5-Year monthly) was 2.376. Turning to its 52-week performance, $2.27 and $0.20 were the 52-week high and 52-week low respectively. Overall, BNGO moved -15.52% over the past month.
Bionano Genomics Inc’s market cap currently stands at around $24.36 million, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 6.3M for the company’s revenue for the quarter, with a low and high estimate of 6M and 6.5M respectively. The average forecast suggests down to a -41.24% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 28.9M, representing a -19.97% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that BNGO is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend BNGO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
BNGO’s current price about -4.75% and -24.68% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.21, while 7-day volatility ratio is 10.48% and 9.88% in the 30-day chart. Further, Bionano Genomics Inc (BNGO) has a beta value of 2.27, and an average true range (ATR) of 0.03. Analysts have given the company’s stock an average 52-week price target of $1, forecast between a low of $1 and high of $1. Looking at the price targets, the low is -316.67% off current price level while to achieve the yearly target high, price needs to move -316.67%. Nonetheless, investors will most likely welcome a -316.67% jump to $1 which is the analysts’ median price.
If we refocus on Bionano Genomics Inc (NASDAQ:BNGO), historical trading data shows that trading volumes averaged 3.09 over the past 10 days and 2.47 million over the past 3 months. The company’s latest data on shares outstanding shows there are 101.99 million shares.
The 0.64% of Bionano Genomics Inc’s shares are in the hands of company insiders while institutional holders own 5.35% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 9.83 million on 2024-10-31, giving us a short ratio of 3.81. The data shows that as of 2024-10-31 short interest in Bionano Genomics Inc (BNGO) stood at 1026.0 of shares outstanding, with shares short rising to 6.07 million registered in 2024-09-30. Current price change has pushed the stock -87.36% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BNGO stock continues to rise going into the next quarter.
